Pharmacotherapy of Mood Disorders
- 1 April 2008
- journal article
- review article
- Published by Annual Reviews in Annual Review of Clinical Psychology
- Vol. 4 (1) , 53-91
Abstract
The mood disorders—primarily major depressive disorder and bipolar affective disorder—constitute one of the world's greatest public health problems and are associated with significant reductions in productivity, health, and longevity. In addition, people who suffer from these common illnesses, along with their families and loved ones, experience an incalculable toll on quality of life. Dating to the introduction of the first effective therapies for mood disorders in the late 1950s and 1960s, various types of pharmacotherapy have become a mainstay for the management of mood disorders, particularly more severe, chronic, and recurrent forms of depression and most forms of bipolar disorder. This review examines recent developments in the pharmacotherapy of both forms of mood disorder, comparing the newer antidepressants such as the selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors with their predecessors (the monoamine oxidase inhibitors and tricyclic antidepressants) and likewise comparing the older standard for management of bipolar disorder, lithium, with newer classes of medications, such as a selected group of anticonvulsants and the atypical antipsychotics. Although these newer classes of medications have generally improved upon the earlier treatments in terms of better tolerability and safety, there are no universally effective pharmacologic treatments for mood disorders, and careful medical management of these medications is still warranted.Keywords
This publication has 159 references indexed in Scilit:
- Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomised controlled trialBMJ, 2007
- A 24‐week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disordersBipolar Disorders, 2007
- Paroxetine and congenital malformations: Meta-Analysis and consideration of potential confounding factorsClinical Therapeutics, 2007
- Effectiveness of Adjunctive Antidepressant Treatment for Bipolar DepressionNew England Journal of Medicine, 2007
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary CareThe World Journal of Biological Psychiatry, 2007
- The armamentarium of treatments for bipolar disorder: a review of the literatureInternational Journal of Neuropsychopharmacology, 2006
- Effects of Risperidone Augmentation in Patients with Treatment-Resistant Depression: Results of Open-Label Treatment Followed by Double-Blind ContinuationNeuropsychopharmacology, 2006
- Sertraline versus imipramine to prevent relapse in chronic depressionJournal of Affective Disorders, 2001
- Comparison of DSM-III-R chronic major depression and major depression superimposed on dysthymia (double depression): Validity of the distinction.Journal of Abnormal Psychology, 2000
- Is psychotherapy an effective treatment for melancholia and other severe depressive states?Journal of Affective Disorders, 1999